Z. Baslar Et Al. , "OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%<= AND > 10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT," 20th Congress of European-Hematology-Association , vol.100, Vienna, Austria, pp.439-440, 2015
Baslar, Z. Et Al. 2015. OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%<= AND > 10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT. 20th Congress of European-Hematology-Association , (Vienna, Austria), 439-440.
Baslar, Z., Eskazan, A. E., Ayer, M., Kantarcioglu, B., Demirel, N., Aydin, D., ... Aydinli, F.(2015). OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%<= AND > 10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT . 20th Congress of European-Hematology-Association (pp.439-440). Vienna, Austria
Baslar, Z. Et Al. "OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%<= AND > 10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT," 20th Congress of European-Hematology-Association, Vienna, Austria, 2015
Baslar, Z. Et Al. "OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%<= AND > 10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT." 20th Congress of European-Hematology-Association , Vienna, Austria, pp.439-440, 2015
Baslar, Z. Et Al. (2015) . "OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%<= AND > 10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT." 20th Congress of European-Hematology-Association , Vienna, Austria, pp.439-440.
@conferencepaper{conferencepaper, author={Z. Baslar Et Al. }, title={OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%<= AND > 10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT}, congress name={20th Congress of European-Hematology-Association}, city={Vienna}, country={Austria}, year={2015}, pages={439-440} }